Sabre (SABR): Constellation’s most asymmetric bet
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
@yenoms One of us! One of us!! $VNO Pref Gang
Continued insider buying from the Chairman of $ALTO ...
Dear $AMC Apes. Your favorite stock is cheaper than last week. Maybe it is time to buy more.
Adient has $435 million of buyback capacity, equal to 38% of its market value, after adding $400 million to its repurchase program.
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Dave & Buster’s faces fourteen straight quarters of same-store sales declines, shrinking margins and a new CEO’s turnaround plan after…
Chord Energy trades at 3x mid-cycle EV/EBITDA with a 15% free-cash-flow yield at $75 WTI, while repurchasing shares and expanding its…
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
HLTRF · long HLS Therapeutics' Clozaril franchise supports downside protection below C$4, while a new product launch provides upside optionality.
UniQure’s Huntington’s disease BLA has a May 1, 2027 priority-review date, with an FDA advisory committee expected in late first quarter.
Floor & Decor cut its 2026 outlook again, with EBITDA guidance falling to $535-550 million and 2027 openings slowing to 10-15 as housing…
F&G’s main insurer held $66.5 billion of assets against $1.38 billion of statutory capital, while private credit, reinsurance dependence…
AutoNation’s new CEO Mike Manley brings Jeep and Fiat Chrysler experience after the dealer chain cycled through three leaders in 30 months.
International Seaways reported $291.4 million of Q3 adjusted net income and has 53% of Q4 booked at strong spot rates, supporting projected…
Peloton’s connected-fitness subscribers fell 9% year over year to 2.475 million, with another high-single-digit holiday decline forecast as…
DHT Holdings earned $1.68 per share in Q3 and projects Q4 EPS of $4.25, supporting a single-quarter dividend above 20% at projected spot…
Lesaka expects its Bank Zero acquisition to close by end-January 2027, though it could still close this calendar year.
WaterBridge grew Q3 revenue 16.9% year over year as Speedway Phase I lifted produced-water volumes, while pursuing large-scale data center…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.